Clinical Trials Logo

Diabetic Foot Infection clinical trials

View clinical trials related to Diabetic Foot Infection.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05174806 Active, not recruiting - Diabetic Foot Clinical Trials

Multi-center Study to Assess Safety, Tolerability and Efficacy of Topical Pravibismane in Moderate DFI Patients

Start date: June 13, 2022
Phase: Phase 2
Study type: Interventional

This is a randomized, open label, controlled, multi-center study to assess safety, tolerability, and efficacy of adjunctive treatment with topically applied pravibismane (MBN-101) in patients with moderate diabetic foot infections. Patients will be randomized in a 2:1 ratio (MBN-101:standard of care). Topical pravibismane (MBN-101) will be applied three times per week for up to 12 weeks. All patients will receive systemic antibiotic treatment for a least a portion of that period. Randomization will be stratified by site.

NCT ID: NCT03010215 Active, not recruiting - Diabetic Foot Ulcer Clinical Trials

Treatment of Chronic Diabetic Foot Ulcers by Minimally Invasive Surgery

DiabeticMIS1
Start date: January 2010
Phase: N/A
Study type: Interventional

Despite the development of the control of DM and the great interest for the complications of the disease, even today the diabetic foot represents a challenge for the orthopaedic surgeon. Being frequently correlated to alteration of the plantar pressures, the surgery treatment is recommended and the Minimally Invasive Surgery (MIS) candidates itself to solve this pathologic case. The purpose of this longitudinal cross-sectional study was to evaluate radiographic and surgical outcomes and the subjective grade of satisfaction of the patients with a diagnosis of chronic plantar diabetic foot ulcers that have been treated at Padua's Orthopaedic Clinic through MIS.